Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial (Q46750773)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial |
scientific article |
Statements
1 reference
Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial (English)
1 reference
Leo G J De Leede
1 reference
John E Humphries
1 reference
Anne C Bechet
1 reference
Ewoud J Van Hoogdalem
1 reference
Ruud Verrijk
1 reference
David G Spencer
1 reference
1 February 2008
1 reference
28
1 reference
2
1 reference
113-122
1 reference
Identifiers
1 reference
1 reference